SCHEMBL17429704

SCHEMBL17429704

COC(=O)c1ccc(CCCc2nc(C)ccc2Br)c(B2OC(C)(C)C(C)(C)O2)c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ UCHL1 P09936 1/20 0.33
▸ CXCR2 P25025 4/20 0.33
▸ MAPK10 P53779 2/20 0.33
▸ USP2 O75604 1/20 0.33
▸ CCR6 P51684 1/20 0.33
▸ HKDC1 Q2TB90 1/20 0.33
▸ NOTUM Q6P988 1/20 0.32
▸ RAB9A P51151 2/20 0.31
▸ GAA P10253 1/20 0.31
▸ KDM4E B2RXH2 2/20 0.31
▸ PTGDR2 Q9Y5Y4 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ RXFP1 Q9HBX9 1/20 0.31
▸ P4HB P07237 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ MGLL Q99685 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17400045 0.90 UCHL1 (0.33) UCHL1CXCR2MAPK10USP2CCR6
SCHEMBL17429645 0.84 TDP1 (0.35) UCHL1CXCR2MAPK10CCR6HKDC1
SCHEMBL17429702 0.83 CXCR2 (0.35) UCHL1CXCR2RAB9AMEN1KMT2A
SCHEMBL17385991 0.82 UCHL1 (0.39) UCHL1CXCR2USP2CCR6HKDC1
SCHEMBL17429652 0.80 UCHL1 (0.33) UCHL1CXCR2MAPK10CCR6HKDC1
SCHEMBL17429651 0.79 CYP4A11 (0.38) UCHL1CXCR2RAB9AGAAKDM4E
SCHEMBL17385776 0.78 UCHL1 (0.38) UCHL1CXCR2USP2CCR6HKDC1
SCHEMBL17400025 0.77 ALDH1A1 (0.39) GAAKDM4EMEN1HPGDKMT2A
SCHEMBL17429646 0.77 CYP4A11 (0.45) RAB9AGAAKDM4EMEN1KMT2A
SCHEMBL17400118 0.76 LIPG (0.37) UCHL1CXCR2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9643946-B2 Tricyclic compound and use thereof SK CHEMICALS CO., LTD. (KR) 2017-05-09 — — US disclosed
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF SK CHEMICALS CO., LTD. (KR) 2016-01-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF GPR65, GPR119, GPR35 UCHL1 4494/4885CXCR2 461/4885MAPK10 615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback